Franklin Resources
CPRX

Franklin Resources’s Catalyst Pharmaceutical CPRX Stock Holding History

Franklin Resources’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3M Buy
416,694
+262,757
+171% +$6.26M ﹤0.01% 1226
2025
Q4 		$3.59M Sell
153,937
-3,842
-2% -$85.6K ﹤0.01% 1552
2025
Q3 		$3.11M Buy
157,779
+17,597
+13% +$362K ﹤0.01% 1625
2025
Q2 		$3.04M Buy
140,182
+61,155
+77% +$1.44M ﹤0.01% 1557
2025
Q1 		$1.92M Buy
79,027
+20,544
+35% +$463K ﹤0.01% 1708
2024
Q4 		$1.22M Sell
58,483
-681
-1% -$14.6K ﹤0.01% 1901
2024
Q3 		$1.22M Buy
59,164
+1,967
+3% +$36.5K ﹤0.01% 1902
2024
Q2 		$886K Sell
57,197
-168,859
-75% -$2.63M ﹤0.01% 1975
2024
Q1 		$3.6M Buy
226,056
+40,133
+22% +$605K ﹤0.01% 1487
2023
Q4 		$3.13M Buy
185,923
+33,397
+22% +$457K ﹤0.01% 1251
2023
Q3 		$1.78M Buy
152,526
+28,327
+23% +$379K ﹤0.01% 1424
2023
Q2 		$1.67M Buy
124,199
+19,770
+19% +$285K ﹤0.01% 1470
2023
Q1 		$1.73M Buy
104,429
+394
+0.4% +$6.5K ﹤0.01% 1396
2022
Q4 		$1.94M Sell
104,035
-31,933
-23% -$492K ﹤0.01% 1371
2022
Q3 		$1.74M Sell
135,968
-382
-0.3% -$4.53K ﹤0.01% 1391
2022
Q2 		$956K Buy
136,350
+84,262
+162% +$618K ﹤0.01% 1550
2022
Q1 		$432K Buy
+52,088
New +$368K ﹤0.01% 1886
2016
Q1 		– Sell
-2,127,100
Closed -$5.21M – 1520
2015
Q4 		$5.21M Hold
2,127,100
– – ﹤0.01% 1123
2015
Q3 		$6.38M Sell
2,127,100
-384,500
-15% -$1.66M ﹤0.01% 1102
2015
Q2 		$10.4M Hold
2,511,600
– – ﹤0.01% 1032
2015
Q1 		$10.9M Hold
2,511,600
– – ﹤0.01% 1035
2014
Q4 		$7.46M Hold
2,511,600
– – ﹤0.01% 1105
2014
Q3 		$8.34M Sell
2,511,600
-77,900
-3% -$204K ﹤0.01% 1077
2014
Q2 		$6.55M Buy
+2,589,500
New +$5.53M ﹤0.01% 1137

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Franklin Resources's CPRX Position: Q1 2026 in Review

Franklin Resources increased its Catalyst Pharmaceutical (CPRX) stake by 171% in Q1 2026, buying an estimated $6.26M and bringing the position to 416,694 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Franklin Resources first reported a position in CPRX in Q2 2014 and has held it in 24 quarters since. The position peaked at $10.9M in Q1 2015. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Franklin Resources held 416,694 shares of Catalyst Pharmaceutical worth $10.3M as of Q1 2026.
  • Franklin Resources bought 262,757 Catalyst Pharmaceutical shares in Q1 2026, an estimated $6.26M.
  • Catalyst Pharmaceutical made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1226 holding.
  • Franklin Resources first reported a position in Catalyst Pharmaceutical in Q2 2014 and has held it in 24 quarters since.
  • Franklin Resources's Catalyst Pharmaceutical position peaked at $10.9M in Q1 2015.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.